No Data
No Data
Q3 Pharma and Biotech Layoffs in Charts: More Than 1000 Each in July and August
Caribou Biosciences to Present Preclinical Data Supporting Development of CB-010 for Lupus at the American College of Rheumatology Convergence 2024
With 60% Ownership, Caribou Biosciences, Inc. (NASDAQ:CRBU) Boasts of Strong Institutional Backing
Vir Biotechnology Names Jason O'Byrne Finance Chief
Truist Financial Initiates Caribou Biosciences(CRBU.US) With Buy Rating
Caribou Biosciences Announces CFO Resignation and Succession Plan
No Data
No Data